Advance furthers stem cells for use in drug discovery, cell therapy – Science Daily
Science Daily |
Advance furthers stem cells for use in drug discovery, cell therapy
Science Daily Stem cells respond to chemical signals that trigger their development into specialized cells in the brain, muscles and blood vessels. In the lab, researchers use a “substrate” material that anchors the cells in place and allows the necessary signaling … |
KCRA Sacramento |
‘Astounding’ gene therapy cancer drug heading for FDA approval
KCRA Sacramento A new gene therapy drug, the first in its class, was recommended for approval to the US Food and Drug Administration by an advisory committee on Wednesday, July 12, 2017. If approved by the FDA, the drug will be a new avenue for some leukemia patients … What Families Need to Know About First Gene Therapy for Deadly Childhood CancerConsumerReports.org FDA Panel Recommends Approval of Novel ‘Gene Therapy‘ for LeukemiaWBUR First gene therapy in the world is here, heralds new era in medicineFinancial Express Sumter Item –The Union Leader all 36 news articles » |
WCVB Boston |
‘Astounding’ gene therapy cancer drug heading for FDA approval
WCVB Boston A new gene therapy drug, the first in its class, was recommended for approval to the US Food and Drug Administration by an advisory committee on Wednesday, July 12, 2017. If approved by the FDA, the drug will be a new avenue for some leukemia patients … What Families Need to Know About First Gene Therapy for Deadly Childhood CancerConsumerReports.org Novel Gene Therapy for Leukemia Clears FDA PanelScientific American FDA Panel Recommends Approval of Novel ‘Gene Therapy‘ for LeukemiaWBUR Trussvilletribune –Financial Express all 42 news articles » |
CBC.ca |
New buzz about immunotherapy
CBC.ca If the FDA gives final approval in the fall, it will be the first time this form of immunotherapy will be commercially available to patients. So far it’s only been tried in formal clinical trial settings. “I think in the field everybody is very excited … |
|
Provia Labs Acquires the Vault Stem Cell Bank’s Dental Stem Cell Client Base and Distribution Agreements
Benzinga Provia Laboratories LLC (“Provia”) completed a transaction with the Vault Biobank (“Vault”) to take over the Vault’s dental stem cell business’ client agreements and distribution agreements. As part of the terms of the transaction, Provia will provide … |